135 related articles for article (PubMed ID: 2604936)
1. The use of an investigational radiopharmaceutical in neuroblastoma: a nursing perspective.
Kelly JU
J Pediatr Oncol Nurs; 1989 Oct; 6(4):133-8. PubMed ID: 2604936
[TBL] [Abstract][Full Text] [Related]
2. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: experience of the Münster/Kassel Group.
Fischer M; Wehinger H; Kraus C; Ritter J; Schröter W
Med Pediatr Oncol; 1987; 15(4):196-8. PubMed ID: 3657707
[TBL] [Abstract][Full Text] [Related]
4. Radiation protection during treatment of children with 131I-meta-iodobenzylguanidine.
van der Steen J; Maessen HJ; Hoefnagel CA; Marcuse HR
Health Phys; 1986 Apr; 50(4):515-22. PubMed ID: 3957673
[TBL] [Abstract][Full Text] [Related]
5. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
6. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Shapiro B; Miser JS; Normole D; Shulkin BL; Francis IR; Zasadny K; Carey JE; Johnson JW
Am J Clin Oncol; 1992 Jun; 15(3):226-32. PubMed ID: 1590275
[TBL] [Abstract][Full Text] [Related]
7. 131I-metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis.
Mastrangelo R; Troncone L; Lasorella A; Riccardi R; Montemaggi P; Rufini V
Am J Pediatr Hematol Oncol; 1989; 11(1):28-31. PubMed ID: 2785352
[TBL] [Abstract][Full Text] [Related]
8. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
Bolster AA; Hilditch TE
Br J Radiol; 1995 Nov; 68(815):1263. PubMed ID: 8542240
[No Abstract] [Full Text] [Related]
10. Considerations on 131I-metaiodobenzylguanidine therapy of six children with neuroblastoma.
Sanguineti M
Med Pediatr Oncol; 1987; 15(4):212-5. PubMed ID: 3657710
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study.
Fielding SL; Flower MA; Ackery D; Kemshead JT; Lashford LS; Lewis I
Eur J Nucl Med; 1991; 18(5):308-16. PubMed ID: 1936038
[TBL] [Abstract][Full Text] [Related]
12. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
Clement SC; van Eck-Smit BL; van Trotsenburg AS; Kremer LC; Tytgat GA; van Santen HM
Pediatr Blood Cancer; 2013 Nov; 60(11):1833-8. PubMed ID: 23832530
[TBL] [Abstract][Full Text] [Related]
14. The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma.
Lashford LS; Moyes J; Ott R; Fielding S; Babich J; Mellors S; Gordon I; Evans K; Kemshead JT
Eur J Nucl Med; 1988; 13(11):574-7. PubMed ID: 3350034
[TBL] [Abstract][Full Text] [Related]
15. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice.
Wafelman AR; Suchi R; Hoefnagel CA; Beijnen JH
Eur J Nucl Med; 1993 Jul; 20(7):614-6. PubMed ID: 8370383
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and therapeutic use of 131I-metaiodobenzylguanidine in children with neuroblastoma.
Claudiani F; Garaventa A; Scopinaro G; Bertolazzi L; Villavecchia GP; Dini G; Lanino E; De Bernardi B; Sanguineti M
J Nucl Med Allied Sci; 1988; 32(1):1-6. PubMed ID: 3404262
[No Abstract] [Full Text] [Related]
17. The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescription.
Fielding SL; Flower MA; Ackery DM; Kemshead J; Lashford LS; Lewis IJ
Radiother Oncol; 1992 Sep; 25(1):73-6. PubMed ID: 1410594
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).
Brendel AJ; Jeandot R; Guyot M; Lambert B; Drouillard J
Clin Nucl Med; 1989 Jan; 14(1):19-21. PubMed ID: 2714036
[No Abstract] [Full Text] [Related]
19. Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
Treuner J; Klingebiel T; Feine U; Buck J; Bruchelt G; Dopfer R; Girgert R; Müller-Schauenburg W; Meinke J; Kaiser W
Pediatr Hematol Oncol; 1986; 3(3):205-16. PubMed ID: 2484676
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with neuroblastoma treated with 125-I MIBG.
Sisson JC; Shapiro B; Hutchinson RJ; Shulkin BL; Zempel S
Am J Clin Oncol; 1996 Apr; 19(2):144-8. PubMed ID: 8610638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]